LSGRX
Price
$34.44
Change
+$0.32 (+0.94%)
Updated
Oct 8 closing price
Net Assets
18.55B
RGACX
Price
$86.09
Change
+$0.64 (+0.75%)
Updated
Oct 8 closing price
Net Assets
340.58B
Interact to see
Advertisement

LSGRX vs RGACX

Header iconLSGRX vs RGACX Comparison
Open Charts LSGRX vs RGACXBanner chart's image
Loomis Sayles Growth Y
Price$34.44
Change+$0.32 (+0.94%)
VolumeN/A
Net Assets18.55B
American Funds Growth Fund of Amer R3
Price$86.09
Change+$0.64 (+0.75%)
VolumeN/A
Net Assets340.58B
LSGRX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
LSGRX vs. RGACX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSGRX is a Buy and RGACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 341B vs. LSGRX (18.5B). RGACX pays higher dividends than LSGRX: RGACX (0.07) vs LSGRX (0.00). LSGRX was incepted earlier than RGACX: LSGRX (34 years) vs RGACX (23 years). RGACX (0.94) is less costly to investors than LSGRX (0.67). RGACX is a more actively managed with annual turnover of: 25.00 vs. LSGRX (10.00). RGACX has a lower initial minimum investment than LSGRX: RGACX (250) vs LSGRX (100000). LSGRX annual gain was more profitable for investors over the last year : 20.46 vs. RGACX (14.19). LSGRX return over 5 years is better than : 49.93 vs. RGACX (40.04).
LSGRXRGACXLSGRX / RGACX
Total Expense Ratio0.660.9470%
Annual Report Gross Expense Ratio0.670.9471%
Fund Existence34 years23 years-
Gain YTD16.50919.58684%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets18.5B341B5%
Annual Yield % from dividends0.000.07-
Returns for 1 year20.4614.19144%
Returns for 3 years89.4474.27120%
Returns for 5 years49.9340.04125%
Returns for 10 years215.52101.32213%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATXS8.400.93
+12.45%
Astria Therapeutics
SCNI1.630.17
+11.64%
Scinai Immunotherapeutics Ltd.
KLIC40.730.68
+1.70%
Kulicke and Soffa Industries
UCL2.30N/A
N/A
uCloudlink Group
HTHT37.78-0.28
-0.74%
H World Group Limited